Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Insilico Medicine Announces First-in-Human Study for Orally PHD Inhibitor ISM5411 for Inflammatory Bowel Disease (IBD)
2023-12-05 06:00
Ubie's AI Symptom Checker Used by 2 Million Americans in First Year, Fueling Pharma Partnerships
2023-12-05 00:00
Pioneering health innovations at China Int'l Supply Chain Expo
2023-12-04 22:20
CARsgen's CT071 Received IND Clearance from the FDA for Treating Relapsed/Refractory Multiple Myeloma or Relapsed/Refractory Primary Plasma Cell Leukemia
2023-12-04 21:50
Technoderma Medicines Completes Phase 1 Dose Escalation Clinical Trial of TDM-180935 for Atopic Dermatitis
2023-12-04 21:13
Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck
2023-12-04 21:05
Crystal Pharmatech's CDMO Business Unit successfully passed the dual certification of GMP and GDP conducted by SGS
2023-12-04 21:00
Mootral introduces new methane reduction technology, doubling efficacy using a well-known natural molecule
2023-12-04 20:00
Latest Updates of Viva's Portfolio Companies
2023-12-04 17:55
Cigna Healthcare Research: People in Hong Kong Have the Lowest Vitality Score in APAC
2023-12-04 17:34
Supercell Acquires Exclusive Licensing from Japanese Immunotherapy Leader for Advanced NK Cell Treatment Technology
2023-12-04 16:39
MeltMed® Rings in the Holidays with Reduced Pricing and New NAD+ Starter Packs
2023-12-04 15:01
First Patient Dosed in Phase Ⅲ Study of JSKN003 for the Treatment of Advanced HER2-Low Breast Cancer
2023-12-04 14:51
Nona Biosciences Announces Collaboration Agreement with Lycia Therapeutics
2023-12-04 13:19
First Patient Dosed in European Named Patient (Early Access) Program for TLX250-CDx, Telix's Kidney Cancer Imaging Agent
2023-12-04 13:00
VISTA Eye Specialist introduces CLEAR - a new generation eye surgery to help patients be glasses free again.
2023-12-04 09:38
The 3rd International Medical Innovation and Cooperation Forum convenes in Fangchenggang
2023-12-04 08:59
Everest Medicines Announces Investigational New Drug Application Acceptance of Zetomipzomib in China
2023-12-04 08:58
"No Perchlorate, Yes Non-electrolysis"...CJ FNT Introduces Natural Cysteine
2023-12-04 08:00
Media Tour Witnesses Chinese Modernization in Hainan FTP
2023-12-03 16:07
1
60
61
62
63
64
1502